SURFACE THERAPEUTICS LTD.
Surface Therapeutics Ltd. is a privately owned drug discovery and development company that is developing new pharmaceutical products for the treatment of inflammatory epithelial diseases; inflammatory conditions of the surfaces of the body, with a focus on the skin and lungs.
SURFACE THERAPEUTICS LTD.
Industry:
Health Care Pharmaceutical
Founded:
2004-01-01
Address:
Abingdon, Oxfordshire, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
Total Funding:
1.5 M GBP
Similar Organizations
ACS Division of Medicinal Chemistry
ACS Division of Medicinal Chemistry is a professional organization for drug discovery and development scientists.
DS Biopharma
DS Biopharma is a privately held drug discovery and development company.
Exo Therapeutics
Exo Therapeutics is a small molecule drug discovery and development company.
Griffin Discoveries
Griffin Discoveries B.V. is a privately-owned drug discovery company.
Summit Therapeutics
Summit Therapeutics is a clinical-stage drug discovery and development company.
Investors List
East Hill Management
East Hill Management investment in Series A - Surface Therapeutics Ltd.
East Hill Management
East Hill Management investment in Seed Round - Surface Therapeutics Ltd.
More informations about "Surface Therapeutics Ltd."
Surface Therapeutics Company Profile 2024: Valuation, Investors ...
Surface Therapeutics’s primary industry is Drug Discovery. Is Surface Therapeutics a private or public company? Surface Therapeutics is a Private company. What is Surface Therapeutics’s …See details»
Surface Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore Surface Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Surface Therapeutics - Ownership and Business Overview - Mergr
Sep 24, 2007 Surface Therapeutics, Ltd. develops drugs and diagnostics for asthma, childhood eczema, and other allergic diseases. Company Summary. SECTOR. Life Science. …See details»
Surface Therapeutics Ltd - Company Profile and News
Company profile page for Surface Therapeutics Ltd including stock price, company news, executives, board members, and contact informationSee details»
Surface Therapeutics Ltd - Oxford University Innovation
Surface Therapeutics Ltd is capitalizing on over 20 years of world leading research from Prof. William Cookson’s laboratory at the Wellcome Trust Centre for Human Genetics. Prof. …See details»
Surface Therapeutics Ltd. - Funding, Financials, Valuation
Surface Therapeutics Ltd. is a privately owned drug discovery and development company. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …See details»
Surface Therapeutics Limited Company Profile, Financial and
DigitGaps report on Surface Therapeutics Limited delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses and structures, and …See details»
Surface Therapeutics Ltd. - life-sciences-europe.com
Nestlé to Acquire Vowst Assets from Seres Therapeutics; Leon-Nanodrugs Closes Series D Led by LBBW Venture Capital; AIRNA Raises $60m Series A Extension Led by Forbion; …See details»
Surface Therapeutics Ltd. - Tech Stack, Apps, Patents ... - Crunchbase
Surface Therapeutics Ltd. is a privately owned drug discovery and development company.See details»
Surface Therapeutics Ltd. - Overview, Competitors, and Employees
View Surface Therapeutics Ltd.'s full profile Surface Therapeutics Ltd. Details Surface Therapeutics Ltd. is a pharmaceuticals company based out of 45 Milton Park, Milton, United …See details»
Surface Therapeutics. - VentureRadar
Oxagen United Kingdom Privately Held Oxagen Limited is a privately held UK biopharmaceutical company developing a pipeline of novel small molecule drugs addressing asthma and other …See details»
Surface Therapeutics - Products, Competitors, Financials, …
Surface Therapeutics is a drug discovery and development company developing innovative new drugs to treat inflammatory epithelial diseases of the skin and lungs. Surface Therapeutics …See details»
Surface Therapeutics Ltd. Asset Profile - Preqin
Surface Therapeutics Ltd is a UK-based company that operates as a developer of drugs and diagnostics for asthma, childhood eczema, and other allergic diseases. Current Investors …See details»
Surface Therapeutics - VentureRadar
Atopix Therapeutics United Kingdom Privately Held Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK, with an innovative …See details»
STP-04 - Drug Targets, Indications, Patents - Synapse - Patsnap
STP-04: a Protease inhibitors Drug, Initially developed by Surface Therapeutics Ltd., Now, its global highest R&D status is Pending, Mechanism: Protease inhibitors, Therapeutic Areas: …See details»
Serentis acquires Surface Therapeutics Ltd. - Crunchbase
Oct 2, 2007 Serentis acquires Surface Therapeutics Ltd. on 2007-10-02 for an undisclosed amount. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... Summary. …See details»
STP-01b - Drug Targets, Indications, Patents - Synapse - Patsnap
STP-01b: a Protease inhibitors Drug, Initially developed by Surface Therapeutics Ltd., Now, its global highest R&D status is Pending, Mechanism: Protease inhibitors, Therapeutic Areas: …See details»
Serentis - Crunchbase Company Profile & Funding
Organization. Serentis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Serentis acquired Surface Therapeutics Ltd. for an …See details»
Serentis - Funding, Financials, Valuation & Investors - Crunchbase
Which types of acquisition does this organization make most frequently? Show . Acquiree Name . Announced Date . Price . Transaction Name . Surface Therapeutics Ltd. Oct 2, 2007 — …See details»